As COVID infections in Massachusetts reach the highest level in months, the arrival of the omicron variant is the latest wrinkle to impact how organizations safely return employees to the workplace. Yet vaccine, booster, and therapeutic advances are providing hope that living with COVID will be manageable. When do we exit a “pandemic” and enter a less threatening “endemic” environment?
Join the Mass High Tech Council on Tuesday, December 14 for our next COVID-19 Recovery and Return to the Workplace Virtual Roundtable, Omicron Variant Updates, and Vaccine and Therapeutic Developments, to gain science-based insights on these issues from the experts.
Beginning at 3:00 pm ET, Dan Barouch, M.D., Ph.D., Director, Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, will join us for an update on the omicron variant. Steve Pagliuca, co-chair of Bain Capital and co-owner of the Boston Celtics, will be joined by Bain Capital Life Sciences Managing Directors Adam Koppel, M.D. Ph.D., and Andrew Hack, M.D., Ph.D. to discuss advances in COVID-19 vaccine and therapeutic developments.